11.79
+0.01
+(0.08%)
At close: January 16 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in CAD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 1 | 3 | 3 |
Avg. Estimate | 154.3M | 151.1M | 593.7M | 624.23M |
Low Estimate | 150.9M | 151.1M | 587.8M | 610.1M |
High Estimate | 157.7M | 151.1M | 600.3M | 638.6M |
Year Ago Sales | 150.9M | 143.58M | 563.98M | 593.7M |
Sales Growth (year/est) | 2.25% | 5.24% | 5.27% | 5.14% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
APYRF | -- | -- | -- | -- |
S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
Maintains | Raymond James: Outperform | 6/22/2023 |
Maintains | Scotiabank: Outperform | 6/22/2023 |
Maintains | Scotiabank: Outperform to Outperform | 4/20/2023 |
Maintains | Scotiabank: Outperform to Outperform | 10/12/2022 |
Maintains | Scotiabank: Outperform to Outperform | 7/29/2022 |
Maintains | Scotiabank: Outperform to Outperform | 7/21/2022 |